- Home
- FMBH vs QURE Comparison
FMBH vs QURE Comparison
Compare FMBH & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMBH
- QURE
- Stock Information
- Founded
- FMBH 1865
- QURE 1998
- Country
- FMBH United States
- QURE Netherlands
- Employees
- FMBH N/A
- QURE N/A
- Industry
- FMBH Major Banks
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- FMBH Finance
- QURE Health Care
- Exchange
- FMBH Nasdaq
- QURE Nasdaq
- Market Cap
- FMBH 860.0M
- QURE 725.4M
- IPO Year
- FMBH N/A
- QURE 2007
- Fundamental
- Price
- FMBH $35.99
- QURE $15.16
- Analyst Decision
- FMBH Hold
- QURE Strong Buy
- Analyst Count
- FMBH 5
- QURE 10
- Target Price
- FMBH $44.00
- QURE $37.20
- AVG Volume (30 Days)
- FMBH 54.3K
- QURE 2.0M
- Earning Date
- FMBH 04-30-2025
- QURE 05-09-2025
- Dividend Yield
- FMBH 2.74%
- QURE N/A
- EPS Growth
- FMBH 8.80
- QURE N/A
- EPS
- FMBH 3.37
- QURE N/A
- Revenue
- FMBH $321,695,000.00
- QURE $20,201,000.00
- Revenue This Year
- FMBH N/A
- QURE $60.54
- Revenue Next Year
- FMBH $4.02
- QURE $183.28
- P/E Ratio
- FMBH $10.44
- QURE N/A
- Revenue Growth
- FMBH 11.71
- QURE 6.30
- 52 Week Low
- FMBH $27.58
- QURE $3.73
- 52 Week High
- FMBH $43.86
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- FMBH 54.20
- QURE 57.88
- Support Level
- FMBH $34.40
- QURE $14.06
- Resistance Level
- FMBH $36.15
- QURE $15.50
- Average True Range (ATR)
- FMBH 0.86
- QURE 1.03
- MACD
- FMBH -0.17
- QURE -0.01
- Stochastic Oscillator
- FMBH 61.54
- QURE 72.12
About FMBH First Mid Bancshares Inc.
First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.